Peptide Repertoires of HLA class I molecules

HLA I 类分子的肽库

基本信息

  • 批准号:
    9316821
  • 负责人:
  • 金额:
    $ 19.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-26 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

Major histocompatibility complex (MHC) class I molecules bind to peptide antigens and present these antigens to CD8 T cells. Human MHC class I variants are encoded by the HLA-A, HLA-B and HLA-C genes. These genes are highly polymorphic. The polymorphisms influence outcomes in a number of infectious diseases, cancers and inflammatory diseases. Among the three HLA class I loci, HLA-B molecules are shown have dominant influences upon outcomes in multiple diseases. A given HLA class I allotype can bind to a large number of cellular and pathogen-derived peptides, collectively called the peptidome. The diversity of HLA-B peptidomes could be one factor underlying their different effects upon disease outcomes. A number of factors are predicted to influence peptidome diversity among HLA class I allotypes, including the structure of the peptide-binding site, the intracellular assembly mechanism and the intrinsic stability of the peptide-deficient form. Several HLA-B molecules are assembled via unconventional intracellular pathways that are suggestive of the presence of novel unconventional epitopes within their peptidomes. We propose to use liquid chromatography mass spectrometry (LC-MS) methods to quantify, characterize and understand the full breadth of the peptidomes of selected HLA-B variants. Based on existing MS datasets, we will also develop globally normalized methods to quantify and compare peptidome diversities of different HLA-B variants. The findings of this study will be significant towards epitope and HLA selection during vaccine design against cancers and infectious diseases. The studies will also establish methods to identify novel disease-relevant epitopes, and allow a better understanding of the relationships between HLA class I genotypes and disease outcomes.
主要组织相容性复合体(MHC)I类分子结合肽抗原, 将这些抗原呈递给CD 8 T细胞。人类MHC I类变异体由 HLA-A、HLA-B和HLA-C基因。这些基因是高度多态的。的 多态性影响许多传染病、癌症和 炎症性疾病。在三个HLA I类基因座中,显示了HLA-B分子, 对多种疾病的结果有显著影响。给定的HLA I类 同种异型可以结合大量的细胞和病原体衍生的肽, 统称为肽组。HLA-B肽段的多样性可能是一个因素 它们对疾病结果的不同影响。许多因素 预测影响HLA I类同种异型之间的肽组多样性,包括 肽结合位点的结构、细胞内组装机制和 肽缺陷形式的内在稳定性。几个HLA-B分子组装在一起, 通过非常规的细胞内途径,这表明存在新的 非常规的表位。我们建议使用液体 色谱-质谱法(LC-MS)定量、表征和 了解所选HLA-B变体的肽段的全部宽度。基于 现有的MS数据集,我们还将开发全球标准化的方法来量化和 比较不同HLA-B变体的肽组差异。这项研究的结果将 对癌症疫苗设计中的表位和HLA选择具有重要意义 和传染病。这些研究还将建立识别新的 疾病相关的表位,并允许更好地了解 HLA I类基因型与疾病结局

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MALINI RAGHAVAN其他文献

MALINI RAGHAVAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MALINI RAGHAVAN', 18)}}的其他基金

HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
HLA I 类肽组多样性和 CD8 T 细胞对 COVID-19 疫苗的反应
  • 批准号:
    10632096
  • 财政年份:
    2022
  • 资助金额:
    $ 19.38万
  • 项目类别:
HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
HLA I 类肽组多样性和 CD8 T 细胞对 COVID-19 疫苗的反应
  • 批准号:
    10523733
  • 财政年份:
    2022
  • 资助金额:
    $ 19.38万
  • 项目类别:
Calreticulin-mediated protein folding in health and disease
健康和疾病中钙网蛋白介导的蛋白质折叠
  • 批准号:
    10599361
  • 财政年份:
    2016
  • 资助金额:
    $ 19.38万
  • 项目类别:
Calreticulin-mediated protein folding in health and disease
健康和疾病中钙网蛋白介导的蛋白质折叠
  • 批准号:
    10362228
  • 财政年份:
    2016
  • 资助金额:
    $ 19.38万
  • 项目类别:
Calreticulin-mediated protein folding in health and disease
健康和疾病中钙网蛋白介导的蛋白质折叠
  • 批准号:
    9095546
  • 财政年份:
    2016
  • 资助金额:
    $ 19.38万
  • 项目类别:
Calreticulin-mediated protein folding in health and disease
健康和疾病中钙网蛋白介导的蛋白质折叠
  • 批准号:
    9238654
  • 财政年份:
    2016
  • 资助金额:
    $ 19.38万
  • 项目类别:
Interactions and mechanisms of function of the TAP complex
TAP 复合体的相互作用和功能机制
  • 批准号:
    7881378
  • 财政年份:
    2009
  • 资助金额:
    $ 19.38万
  • 项目类别:
Calreticulin's functions in the adaptive immune response
钙网蛋白在适应性免疫反应中的功能
  • 批准号:
    7881344
  • 财政年份:
    2009
  • 资助金额:
    $ 19.38万
  • 项目类别:
Calreticulin's functions in the adaptive immune response
钙网蛋白在适应性免疫反应中的功能
  • 批准号:
    7924278
  • 财政年份:
    2009
  • 资助金额:
    $ 19.38万
  • 项目类别:
Calreticulin's functions in the adaptive immune response
钙网蛋白在适应性免疫反应中的功能
  • 批准号:
    7213582
  • 财政年份:
    2007
  • 资助金额:
    $ 19.38万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 19.38万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了